Press Releases
Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon | PRLog
Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon. Global Antipsychotics Market Is Expected To Decline Due To Patent Expiries of Major Drugs - PR11777417
Growing Concern About Anticonvulsant Birth Defects Prompts Wall Street Journal Report and Expanded
As concern mounts over rising reports of birth defects linked to prescription medication use in the United States, the Wall Street Journal covers the issue in a March 2011 article entitled “Can Mom’s Medicine Hurt the Baby?”. In response, The Consumer Justice Foundation adds expanded resources for
Medical News: Ziprasidone Okayed for Bipolar Disorder - in Psychiatry, Bipolar Disorder from
The FDA has approved another antipsychotic agent -- ziprasidone (Geodon) -- for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate.
Reportlinker Adds Prescription Drugs Report
The report provides separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015. A five-year historic analysis is also provided for these markets.
HOPKINS SCIENTISTS UNCOVER CAUSE OF ANTIPSYCHOTIC DRUG WEIGHT GAIN
Johns Hopkins brain scientists have hit on how and why some powerful drugs used for treating mental illnesses cause patients to gain so much weight that they often develop life-threatening complications such as diabetes and heart disease.
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015) | PRLog
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015). Renub Research has announced the addition of the Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015) - PR11734706
Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018 | PRLog
Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The Bipolar Disorder Therapeutics Market is Forecast to Show Slow Growth until 2018 - PR11720335
Another Health Canada Warning Against Psychiatric Drugs | PRLog
Another Health Canada Warning Against Psychiatric Drugs. The fact is, there is nothing in any medical or scientific literature that confirms the existence of Attention-Deficit/Hyperactivity Disorder (ADHD). - PR11596984
Popularity of Seroquel 100 mg Revealed Through Multi Million Settlement
Popularity of Seroquel 100 mg Revealed Through Multi Million Settlement. CanadaDrugsOnline.com is the industry leading Canadian pharmacy and we set the standards when it comes to low pricing, excellent customer service, and fast shipping. - PR11470652
Topamax Birth Injury Resources and the Wall Street Journal Report on Growing Concern over Potential
As the FDA changes the pregnancy category of migraine drug Topamax to a class D drug, worry over the lack of drug testing for birth defects increases. The Wall Street Journal reports on a history of birth defects related to medications and pregnancy. Topamax Birth Injury Resources provides
Refine by Content Type:
Refine by Source:
- www.prlog.org (7)
- www.prweb.com (2)
- news.prnewswire.com (1)
- www.hopkinsmedicine.org (1)
- www.medpagetoday.com (1)
